Medindia

X

Reportlinker Adds Ovarian Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Wednesday, December 16, 2009 Cancer News J E 4
Advertisement


NEW YORK, Dec. 15 Reportlinker.com announces that a new market research report is available in its catalogue:

Ovarian Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

http://www.reportlinker.com/p0167292/Ovarian-Cancer---Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html

Ovarian Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist's new report, "Ovarian Cancer- Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global ovarian cancer market. The report identifies the key trends shaping and driving the global ovarian cancer market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global ovarian cancer sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

Scope

The scope of the report includes:

- Annualized global ovarian cancer market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.

- Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.

- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.

- Analysis of the current and future market competition in the global ovarian cancer market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with ovarian cancer.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global ovarian cancer market.

- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global ovarian cancer market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What's the next big thing in the global ovarian cancer market landscape? - Identify, understand and capitalize.

Table of Contents

1 Ovarian Cancer Market: Executive Summary

2 Table of Contents

2.1 List of Tables

2.2 List of Figures

3 Ovarian Cancer Market: Market Characterization

3.1 Overview

3.2 Ovarian Cancer Market Size

3.3 Ovarian Cancer Market Forecast and CAGR

3.4 Drivers and Barriers for Ovarian Cancer Market

3.4.1 Drivers for Ovarian Cancer Market

3.4.2 Barriers for Ovarian Cancer Market

3.5 Opportunity and Unmet Need

3.6 Key Takeaway

4 Ovarian Cancer Market: Competitive Assessment

4.1 Overview

4.2 Strategic Competitor Assessment

4.3 Product Profiles of the Major Marketed Products

4.3.1 Overview

4.3.2 Efficacy

4.3.3 Safety Profile

4.3.4 Pricing

4.3.5 Clinical Study Details

4.4 Key Takeaway

5 Ovarian Cancer Market: Pipeline Assessment

5.1 Overview

5.2 Strategic Pipeline Assessment

5.2.1 Technology Trends Analytical Framework

5.3 Ovarian Cancer Therapeutics - Promising Drugs under Clinical Development

5.4 Molecule Profiles of Promising Drugs under Clinical Development

5.4.1. Overview

5.4.2 Efficacy

5.4.3 Safety

5.4.4 Clinical Study Details

5.5 Ovarian Cancer Therapeutics Market - Clinical Pipeline by Mechanism of Action

5.6 Ovarian Cancer Pipeline - Pipeline by Clinical Phases of Development

5.6.1 Ovarian Cancer Therapeutics - Phase III Clinical Pipeline

5.6.2 Ovarian Cancer Therapeutics - Phase II Clinical Pipeline

5.6.3 Ovarian Cancer Therapeutics - Phase I Clinical Pipeline

5.6.4 Ovarian Cancer Therapeutics - Preclinical Pipeline

5.6.5 Ovarian Cancer Therapeutics - Discovery Pipeline

5.7 Discontinued / Suspended Drugs for Ovarian Cancer

5.8 Key Takeaway

6 Ovarian Cancer Market: Implications for Future Market Competition

7 Ovarian Cancer Market: Future Players in Ovarian Cancer Market

8 Ovarian Cancer Market: Appendix

8.1 Definitions

8.2 Acronyms

8.3 Research Methodology

8.3.1 Coverage

8.3.2 Secondary Research

8.3.3 Forecasting

8.3.3.1 Epidemiology-based Forecasting

8.3.4 Primary Research

8.3.5 Expert Panel validation

8.4 Contact Us

8.5 Disclaimer

8.6 Sources

List of Tables

Table 1: Global Ovarian Cancer Treatment by Stage of the Disease, 2009

Table 2: Global Ovarian Cancer Therapeutics Market, Revenue Forecasts ($ m), 2001-2009

Table 3: Global Ovarian Cancer Therapeutics Market, Revenue Forecasts ($ m), 2009-2016

Table 4: Major marketed products comparison in Ovarian Cancer, 2009

Table 5: Ovarian Cancer Therapeutics - Most Promising Drugs Under Clinical Development, 2009

Table 6: Ovarian Cancer Therapeutics - Phase III Clinical Pipeline, 2009

Table 7: Ovarian Cancer Therapeutics - Phase II Clinical Pipeline, 2009

Table 8: Ovarian Cancer Therapeutics - Phase I Clinical Pipeline, 2009

Table 9: Ovarian Cancer Therapeutics - Preclinical Pipeline, 2009

Table 10: Ovarian Cancer Therapeutics - Drug Discovery Pipeline, 2009

Table 11: Ovarian Cancer Therapeutics - List of Discontinued Drugs, 2009

List of Figures

Figure 1: Global Ovarian Cancer Therapeutics Market Forecast, 2000-2015

Figure 2: Ovarian Cancer Therapeutics Market - Opportunity and Unmet Need, 2009

Figure 3: Ovarian Cancer Therapeutics Market - Strategic Competitor Assessment, 2009

Figure 4: Technology Trends Analytic Framework of the Ovarian Cancer Pipeline, 2009

Figure 5: Technology Trends Analytic Framework of the Ovarian Cancer Pipeline - Description, 2009

Figure 6: Ovarian Cancer Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2009

Figure 7: Ovarian Cancer Pipeline by Phase of Clinical Development, 2009

Figure 8: Ovarian Cancer Therapeutics Market - Strategic Competitor Assessment, 2009

Figure 9: Ovarian Cancer Therapeutics Market - Clinical Pipeline by Company, 2009

Figure 10: GlobalData Methodology

Figure 11: GlobalData Market Forecasting Model

To order this report:

Pharmaceutical Industry: Ovarian Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

More Market Research Report

CONTACT: Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds The Future of Biosimilars - Mar...
S
Reportlinker Adds Epilepsy - Drug Pipeline Analysi...